Early Enthusiasm for Cancer Drug Reformulated for Ophthalmic Use

(MedPage Today) -- SEATTLE -- An ocular implant containing a reformulated cancer drug preserved vision and stabilized retinal thickening for up to a year while dramatically reducing treatment burden for neovascular age-related macular degeneration...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news